Description
ARA 290, also known as cibinetide, is a cutting-edge 11-amino acid peptide derived from erythropoietin (EPO). This innovative compound stands out for its ability to activate the body’s innate repair receptor, delivering targeted benefits without the side effects typically associated with EPO derivatives.
Targeted Inflammation Reduction
One of ARA 290’s remarkable properties is its capacity to reduce inflammation effectively. By interfacing with the innate repair receptor, it provides precise modulation of inflammatory responses, enhancing the body’s natural healing process.
Supports Nerve Fiber Recovery
ARA 290 is uniquely designed to support nerve fiber recovery, restoring damaged areas and promoting healthy function. It represents a promising tool in scientific endeavors aimed at addressing nerve-related challenges.
Non-Stimulatory Action on Hematocrit
Unlike traditional EPO derivatives, ARA 290 does not stimulate red blood cell production or raise hematocrit levels, making it a specialized compound with a distinct application range. This focus on safety and precision underscores its value in research applications.
Note: For research and laboratory use only. Not intended for human or clinical consumption.





Reviews
There are no reviews yet.